High-volume independent Manhattan pharmacy

BizGeno summary

An independent pharmacy reporting substantial annual sales and SBA approval. The headline revenue creates scale, but reimbursement mix, prescription concentration, inventory, licensing, audits, working capital, and owner or pharmacist coverage determine the real risk profile.

What stands out

• The marketplace summary reports $11.5 million in revenue and $480,000 in cash flow.
• The listing states SBA approval up to $1.3 million.
• The business operates in Manhattan.

Questions worth asking

1. What payer and prescription concentration drives sales?
2. What audits, clawbacks, or compliance matters exist?
3. How much inventory and working capital are needed?
4. Which pharmacist licenses and staffing obligations transfer?